Connect with us

Cannabis News

New Hampshire Lawmakers Take Up Bipartisan Bills To Legalize Psilocybin For Medical Use

Published

on

New Hampshire lawmakers on Wednesday took up a pair of bipartisan bills to legalize the regulated use of psilocybin for medical purposes.

At a hearing before the House Health, Human Services and Aging Committee, members heard public testimony on the proposals: HB 1809 by Rep. Buzz Scherr (D) and HB 1796 by Rep. Michael Moffett (R).

Both measures seek to create a regulatory pathway for patients with certain conditions to access psychedelics for therapeutic use through a program overseen by the state Department of Health and Human Services (DHHS). But Moffett’s legislation has more mandates about the regulatory framework.

“I’m hardly a major supporter of a measure like this,” Moffett told lawmakers at the hearing, saying he’s “always been very wary and skeptical” of psychedelics and has “always been averse to marijuana for many reasons, including the fact that I was constantly drug tested over many years in the Marine Corps and developed zero tolerance for illegal drug use.”

He said he changed his mind after seeing a presentation on psychedelic therapies at a national veterans conference last summer, where he learned that “a psilocybin treatment option can work for almost anyone, beyond military or ex-military.”

Scher, for his part, said that “a large amount of research is currently being done on the therapeutic uses of psilocybin.”

“Research to help those with treatment-resistant depression is pretty important right now,” he said. “Research is being developed on its broader use for those suffering from other types of PTSD. Research is also being developed on its use with people with other types of substance abuse.”

Jenny O’Higgins of the state Department of Health and Human Services said officials have some concerns about the lack of matching funds in Moffett’s legislation, saying the department “wouldn’t be able to absorb” the program under its current budget.

A representative of Smart Approaches to Marijuana’s New Hampshire affiliate testified against the proposals, saying psilocybin is an illegal Schedule I drug. He also argued that there is insufficient evidence to support the therapeutic potential of psychedelics.




Here are the main provisions HB 1809:

  • DHHS would be responsible for approving licensed medical professionals who are able to act as psilocybin providers for patients.
  • To qualify for the program, patients must be diagnosed with treatment-resistant depression, post-traumatic stress disorder (PTSD), substance use disorder, or another condition approved by an advisory board and DHHS.
  • The legislation specifically states that only natural psilocybin could be administered, excluding synthetic versions of the psychedelic.
  • Suppliers would also have to be approved by the department to grow and harvest their psilocybin products.
  • The process of treating qualifying patients with psychedelics should include a preparation session, an administration session, and an integration session.
  • A Medical Psilocybin Advisory Committee would be established, consisting of a DHHS representative, a qualified patient, a veterans advocate, and eight medical professionals.
    • Those medical experts should include a psychedelic researcher, two regulators overseeing existing medical psilocybin programs, and specialists in addiction treatment, palliative care, veterans affairs, naturopathy, nursing and mental health counseling.
  • The commission would look at DHHS’ data on patient outcomes, add requirements for participation in the program and decide whether to expand the law.
  • The program would be implemented if the advisory committee, within two years of the bill’s passage, notifies lawmakers, regulators and the governor that it can be effectively administered.

“The medical community has always recognized that patients have serious conditions that are highly resistant to effective treatments,” reads a statement of purpose for the measure. “Recently, studies have begun to show that some of these patients have had positive outcomes with closely supervised use of psilocybin for treatment.”

“Patients with significant post-traumatic stress disorder, treatment-resistant clinical depression, and severe substance use disorder have been shown to benefit from controlled, therapeutic use of psilocybin in a supervised setting,” he says. “The purpose of this action is to create a carefully controlled and closely supervised environment in which an approved medical provider can treat a carefully selected patient with appropriate doses of psilocybin produced by the same provider for a medical intervention.”

Here are the main details HB 1796:

  • The bill would allow for the regulated use of psilocybin in a medically supervised setting, and DHHS would be responsible for overseeing the program.
  • To be eligible for psilocybin treatment, a patient 21 years of age or older must be diagnosed with treatment-resistant depression, PTSD, substance abuse disorder, a terminal illness requiring end-of-life care, or any other condition authorized by DHHS.
  • A Psilocybin Licensing Board under the department will be responsible for licensing independent medical psilocybin suppliers, therapy providers, cultivation and testing laboratories.
  • There would be specific guidelines for facilities where psychedelics can be administered, including safety requirements and other safety protocols, such as ensuring that rescue medication is on site in case a patient experiences an adverse event.
  • The legislation would also establish a Psilocybin Therapeutic Treatment Fund, which would be funded by revenue from licensing taxes and fees. The funds would go towards studies on the possibility of expanding the program to include additional psychedelics in the program.
  • If the law is approved, it would take effect on January 1, 2027.

“The purpose of the Therapeutic Psilocybin Act is to allow the beneficial use of psilocybin for the relief of qualified medical conditions in a regulated system,” the bill’s purpose statement reads.

The chances of the bill moving forward this session are unclear, but lawmakers have become increasingly active in recent years in support of psychedelic reform.

Last June, the New Hampshire Senate voted to repeal the compromise legislation It would lower the state’s criminal penalty for first-time possession of psilocybin also creating mandatory minimum sentences for fentanyl.

As originally introduced, the legislation would completely remove the penalties for obtaining, purchasing, transporting, possessing or using psilocybin, effectively legalizing it on an off-trade basis. However a The House Committee amended the bill before it could advance unanimously last march

Meanwhile in New Hampshire, the House last week passed a bill to legalize marijuana in the state– Although his chances of passing to the Senate remain doubtful, and the governor has expressed a clear position against the reform.

Also last week, the chamber approved a proposal to make medical cannabis dispensaries into non-profit businesses.

The legalization bill sponsored by Rep. Jared Sullivan (D) is one of several cannabis proposals filed for the 2026 session, including legislation by Rep. Jonah Wheeler (D) that seeks to put a constitutional amendment on the state ballot. let voters decide whether they want to legalize marijuana for adults 21 and older“having a modest amount of cannabis for their personal use.”

Gov. Kelly Ayotte (R) has already threatened to veto the legalization bill that reaches his desk, even though the proposal to amend the Constitution would not require gubernatorial action.

The governor said in August his position on the reform it would not change, even if the federal government moved forward with reorganizing the plant. Since then, President Donald Trump has ordered the attorney general to complete the process of moving cannabis from Schedule I to III of the Controlled Substances Act (CSA).

At a committee meeting last year, Sullivan ultimately made a persuasive argument for moving forward with his legalization bill, pointing out. The House has repeatedly passed similar legislation and that the House should stand its ground, forcing the Senate and the governor to once again oppose a policy that is popular with voters.

“We know where it’s going. Let’s send a virtue signal,” Sullivan said. “Let them be the ones to piss off the voters who care about this.”

Meanwhile, the House also passed a bill by Rep. Wendy Thomas (D) last week allow medical marijuana dispensaries (known in the state as “alternative treatment centers” or ATCs) to convert their dispensary licenses into nonprofit entities.. HB 54, which adopted a concurrence schedule with other laws, had previously advanced unanimously out of the House Finance Committee.

Part of the motivation behind the legislation is the fact that medical marijuana dispensaries are not for-profit federal states. But in the state, they are considered non-profit organizations, which has disproportionately increased their operating costs.

Other bills introduced in 2026 include two proposals to protect the gun rights of medical cannabis patients.

There’s also some legislation aimed at regulating the sale of hemp, an issue that’s getting a lot of attention since Congress passed and Trump signed an appropriations bill that would effectively re-criminalize most consumable hemp products.

Meanwhile, after the House added provisions to a bill passed by the Senate last year that would have allowed medical marijuana patients to grow cannabis at home, those measures were removed in the conference.

user photo CostaPPR.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

When we decided to start our own hydroponic farm, we were always open to the possibility of growing cannabis down the road

Published

on

By

Farm Girl Greens launched in Auburn, New York in late 2019 as a vertical hydroponic leafy greens operation supplying restaurants and farmers markets. The business remained profitable due to changing sales channels, fluctuating grant funding and rising energy costs, but the financial model was becoming increasingly difficult to predict.

When New York legalized adult cannabis and implemented a micro-business licensing structure, the regulatory landscape changed. The subsequent pivot was not sudden, according to co-owner Abby Lepak, but rather the activation of a long-considered opportunity. “When we decided to start our hydroponic farm, we were always open to growing cannabis,” he explains. “At the time, cannabis wasn’t legal in New York state, so our initial business plan was focused on leafy greens.”

© Green farm girls
Farm Girl Greens grow room showing off ZipGrow mobile tower trellis under LED lighting

Market volatility and margin pressure
The farm planted the first seeds in November 2019. By March 2020, the restaurant and farmers market channels had either closed or switched to takeout. “Running a business in the early 2020s was a challenge for any small business owner,” says Lepak. “We were successful in the beginning because of the grocery store supply chain and consumers wanting to buy directly from farmers.”

Farm Girl Greens focused on weekly home deliveries through a distributor as well as its own logistics. As restaurants reopened, sales shifted to food service accounts, reducing margins compared to direct-to-consumer channels. “It was profitable but not so predictable,” says Lepa about the green phase.

An additional outlet was operated by a non-profit nonprofit that supplied food pantries at retail prices by paying subsidies rather than consumers. “The food was free to the consumer, but the funding was unpredictable and then dwindled.”
Utility costs added further pressure. Rising energy bills prompted the farm to build a grant-funded solar installation. The system remains in effect today. “New York state is seeing energy costs double from one month to the next right now,” Lepak says. “Not just for companies.” Profitable but subject to fluctuating demand, unstable funding streams and rising operating costs, the green model became more difficult to plan.

© Green farm girls

A microenterprise license changes the model
Legalization introduced another option. Farm Girl Greens obtained a Micro Business License from the Office of Cannabis Management, New York’s governing body for adult cannabis. “The emerging market of adult-use cannabis cultivation has a bright future,” says Lepak. “The Bureau of Cannabis Management has taken steps to prevent large growers from flooding the market. Because we are a small grower and a predominantly female-owned business, we have been able to take advantage of training and fees at reduced prices and sometimes at no cost.”

The license allows cultivation, processing, distribution and retailing under one structure. For now, the farm is cultivating and shaking the flowers, using a third-party processor to extract them, and selling wholesale to pharmacies. As an indoor micro-business, the production covers 3,500 square feet of space and processes 1,700 pounds of cannabis per year.

Different crop, different system
Change required new infrastructure. The ZipGrow tower system used for leafy greens has been replaced with a high-pressure aeroponic recirculation system designed by Current Culture, along with a vertical rack from Pipp Horticulture.

“The leafy greens in our ZipGrow system didn’t require as much space and had a shorter seed-to-harvest cycle,” says Lepak. At peak production, the farm harvested the equivalent of 1,500 heads of lettuce per week while planting another 1,500 seeds.

Indoor cannabis works on a longer cycle, usually between 90 and 100 days. With a flower room currently in operation, the farm expects five harvests a year at full production. A second flower room is planned. Once built, a staggered planting schedule would allow ten harvests per year.

© Green farm girls

Higher margins, higher limits
Per square foot, cannabis offers stronger margins than leafy greens, Lepak says. But regulatory costs and add-ons dampen this advantage. “We expect margins to increase as cannabis legalization and additional fees decrease. These fees are very close to being cost prohibitive.”

Compliance-related packaging requirements and limited access to banking continue to weigh on profitability. Job applications have also changed. Leafy greens required a steady weekly workforce to manage the cycles and distribution of perishable crops. Growing cannabis involves less daily handling, but requires more concentrated work during the harvest and processing periods.

© Green farm girls
A member of the Farm Girl Greens team transplants seedlings (left) and inside a Matrix Media ZipGrow tower channel (right)

Looking back
Despite the transition, Lepa says he would still start with green leaves. “I enjoyed learning the process of indoor growing and selling at farmers markets,” she says. “Being a grower that delivers product directly to a consumer was a joy for me.”

Farm Girl Greens is selling its ZipGrow tower inventory as it consolidates its cannabis growing operations. “We have a total of 630 towers and associated lights and are willing to sell 450 towers, 180 towers or all 630 together,” says Lepak. “The eight-foot towers are mounted in 21 racks of 30 units. Complete system purchase of all 630 towers includes additional climate control equipment at no additional cost: CO2 generator and vertical V-Flow fans.”

Those interested in buying towers can go directly to Lepak (email protected).


A video tour of the Farm Girl Greens farm setup

© Green farm girls
Complete design of the ZipGrow tower system inside the farm

For more information:
Green Farm Girls
Abby Lepak, co-owner
(email protected)
www.instagram.com/farmgirlgreens

Continue Reading

Cannabis News

Colorado Lawmakers Reject Bill That Would Have Put Marijuana And Alcohol Tax Hike On Ballot To Fund Mental Health Treatment

Published

on

By

Colorado lawmakers have rejected a bill that would have put a measure on the state’s November ballot that would have asked voters. increase taxes on marijuana and alcohol to support mental health treatment.

Following the recommendation of the bicameral Capital Development Committee (CDC) last week, members of the House Health and Human Services Committee on Wednesday defeated the legislation in a 7-6 vote by Senators Bob Marshall (D) and Judy Amabile (D).

“We’ve made our criminal system the default mental health system for people over 18. It’s been a travesty,” Marshall said Wednesday before the panel’s vote to reject his bill. “It’s been a known plague for years and years and years, and yet nothing is happening to fix the problem.

“At the end of the day, this is something that has to be done,” the sponsor said of HB 1301, which would raise taxes on substances and raise additional revenue to create a mental health fund overseen by the state Department of Human Services (DHS). “And if we don’t do it now, the problem will only get worse.”

If it had advanced in the Legislature, voters across the state would have decided to raise the state’s retail marijuana sales and excise tax by 0.42 percentage points on the November ballot. Taxes on alcohol would also rise for the first time in more than 30 years, at varying levels depending on the type of product.

“The bill requires the treasurer to transfer to the hospital support account created in the capital building fund an amount equal to the tax revenue obtained as a result of the bill,” the summary summarizes. measure he said DHS would be able to spend the funds “in order of priority,” starting with establishing a mental health institute in Aurora, then going toward the institute’s operational costs and a “long-term civil commitment facility” in Mesa County.

Under the amendments passed in committee on Wednesday, the tax increase on alcohol would be reduced slightly, but not for cannabis. The bill’s title was also revised in response to input from the state attorney general, and a fiscal note was added to the $14,000 in programmatic costs, which the sponsor said would come out of the general fund.

At last week’s CDC meeting, Rep. Tammy Story (D), the panel’s vice chairwoman, asked Marshall’s House bill sponsor how the proposal to raise marijuana taxes reconciles the fact that the state has seen a decline in cannabis sales and resulting revenue in recent years. Marshall said he appreciated the concerns, but had no plans to decriminalize cannabis.

“In looking back maybe a the sales the tax maybe be be better,” Marshall admitted Wednesday. “But is in the year has the title now—the tax good harmful substances’—and we put marijuana in the year there in has the suggestion of a couple of has sheriffs, simply to share it has pain, so to talk.”

Marijuana industry representatives have it criticize The bill’s marijuana tax provision is partly because the state already imposes significant taxes on cannabis sales compared to other states and products. Making it more expensive for consumers to buy marijuana from licensed dealers could also hurt efforts to stamp out the illegal market by drawing buyers to unlicensed sources that won’t generate tax dollars for the state.

In the meantime the state is expected to exceed $1 billion in marijuana sales by 2025, a milestone the governor announced in December.tax revenue from cannabis sales has steadily declined over the past five years as more states have implemented legalization and intoxicating hemp products have grown in popularity. However, cannabis brings in more tax dollars than alcohol or cigarettes.

Adult marijuana is currently taxed at three levels in Colorado: a 15 percent excise tax, a 15 percent excise tax, and a general state sales tax of 2.9 percent. As one of the first states to legalize recreational marijuana, Colorado’s revenue from such sales “grew steadily over the first eight years of legalization to $424.4 million by 2020-21,” according to a state report released last month.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Meanwhile, the Colorado House of Representatives sent a bill to the governor last week allow terminally ill patients to use medical marijuana in healthcare facilities such as hospitals. Advocates have been critical of the changes made throughout the legislative process; for example, arguing that hospitals would be right to do so. option– than mandate—The use of medical cannabis in their facilities fundamentally undermines the intention of the reform.

Gov. Jared Polis (D) also said last month his state did not have to join a lawsuit supporting a federal ban on the possession of guns by people who use marijuana that recently went before the US Supreme Court, and he personally opposes the state attorney general’s “legal position on this.”

user photo Brian Shamblen.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Tilray purchases BrewDog’s US assets

Published

on

By

Tilray Brands has signed an asset purchase agreement to acquire some of BrewDog’s strategic assets in the United States, including a brewery, pub and hotel in Columbus, Ohio, as well as New Albany, Ohio, Cleveland, Ohio and Las Vegas, Nevada. As one of Ohio’s largest craft beer brands, this acquisition aligns with Tilray’s regional jewelry strategy.

Irwin D. Simon, President and CEO of Tilray Brands, said: “The acquisition of BrewDog’s key US assets strengthens our US beverage platform and advances our regional craft beer strategy in North America. BrewDog has built a strong following and established a highly visible presence in Las Vegas, including a Las Vegas flagship pub model, creating destination spaces that deepen consumer engagement, offering new opportunities to introduce and sell a broader portfolio of Tilray beverage brands.” meanwhile”.

Mr. Simon continued: “This transaction reinforces Tilray’s acquisition of BrewDog’s operational assets, building on previously announced deals in the UK, Ireland and Australia. Tilray now owns the BrewDog brand and its intellectual property worldwide. This positions us to lead the next chapter of the brand with a highly integrated North American footprint and a long-term publishing strategy designed for joint growth and brand strength.”

Under the asset purchase agreement, Tilray will acquire BrewDog’s US manufacturing and brewing operation in Columbus, Ohio, three Ohio pubs (Columbus, New Albany and Cleveland), a hotel in Columbus, Ohio, and a BrewDog franchise location in Las Vegas, Nevada, and a licensed BrewDog airport location in Denver, Colorado. The transaction is expected to close in the first quarter of 2026, pending customary regulatory approvals.

For more information:
Tilray
www.tilray.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media